Maybank Marathon 2023, 'Elite' Label Road Race, achieves active participation of over 13,600 runners
Maybank Marathon 2023, 'Elite' Label Road Race, achieves active participation of over 13,600 runners
Source: newsmaker.com.au
📰 Extra Joss News
Extra Joss News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Extra Joss. Real-time updates on events, politics, business and more.
Maybank Marathon 2023, 'Elite' Label Road Race, Achieves Active Participation Of Over 13,600 Runners
BALI, INDONESIA, Aug 28, 2023 - (ACN Newswire) - The first and only 'Elite' Label Road Race event in Indonesia, Maybank Marathon, organized by PT Bank Maybank Indonesia Tbk (Maybank Indonesia), took place on Sunday, 27 August 2023 at Bali Safari & ...
Source: scoop.co.nz
VAR technology not available for FA Cup semis
Video assistant referee (VAR) technology will not be available for the semi-finals of the FA Cup to take place at the end of June.
Malaysia General Referees Committee Datuks Sivasundaram Malaysian Football League Football Association Of Malaysia Committee Meeting At Wisma Malaysia Cup
Source: harakahdaily.net
Say Yalla Bola To Lucky Draw Prizes, Games, And Fun With Shahrom Kalam
Whenever a global sporting event is happening, Malaysians from all walks of life come together to support their favourite team. Crowds of people who don’t
Source: ringgitplus.com
Yogi Tapanati Simbolon signs on with BBDO Indonesia as new Creative Lead
BBDO Indonesia has recently brought on board local creative talent, Yogi Tapanati Simbolon as its new Creative Lead.
Source: campaignbriefasia.com
BBDO Indonesia Powers Up With Yogi Tapanati Simbolon
BBDO Indonesia powers up with Yogi Tapanati Simbolon
Source: adgully.com
AFL optimistic M3 League will run smoothly next year
The Amateur Football League (AFL) is optimistic that the Malaysian League’s (M-League) third division competition - the M3 League ...
Malaysia General Asep Dasuki Datuk Mohd Yusoff Mahadi Mohd Yusoff Football Association Of Malaysia Football League
Source: harakahdaily.net
PT Kalbe Farma Tbk (via Public) / Kalbe Gets Phase-2 Clinical Trial Approval on COVID-19 Drug
Kalbe Gets Phase-2 Clinical Trial Approval on COVID-19 Drug - GX17 Kalbe Gets Phase-2 Clinical Trial Approval on COVID-19 Drug - GX17 Jakarta, 30 December 2020 - PT Kalbe Farma Tbk (Kalbe) through its subsidiary PT Kalbe-Genexine Biologics (KGBio) today has received approval for a clinical trial (PPUK) from the Food and Drug Administration of the Republic of Indonesia (BPOM) to carry out Phase 2 clinical trials of the drug GX-17, which is an immunotherapeutic drug that will be developed as a tr...
South Korea Jakarta Raya Republic Of Indonesia Kalbe Genexine Biologics Asia Pacific Kalbe Genexine Biologics Kgbio
Source: publicnow.com